Protective effects of repetitive transcranial magnetic stimulation against 6-OHDA-induced Parkinson's symptoms in a mice model: the key role of miR-409-3p/PDHB axis
- PMID: 34078216
- DOI: 10.1080/00207454.2021.1938037
Protective effects of repetitive transcranial magnetic stimulation against 6-OHDA-induced Parkinson's symptoms in a mice model: the key role of miR-409-3p/PDHB axis
Abstract
Aim: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique showing improvement effects on Parkinson's disease (PD). Multiple microRNAs (miRs) are dys-expressed during the progression of PD. In the current study, the potential involvement of miRs in the anti-PD effects of rTMS was explored.
Methods: PD symptoms were induced in mice with 6-OHDA. The expression profile of miRs influenced by rTMS in PD mice was detected by microarray technique and validated by RT-qPCR detection. The PD mice were treated with rTMS and the changes in cognitive behaviors, substantia nigra neuron number, brain histology, and Aβ1-42 level were detected. The activity of miR-409-3p/PDHB axis was also detected to preliminarily explain the interaction between miRs and rTMS.
Results: The detection of microarray showed that 266 miRs were dys-expressed in PD mice after the administration of rTMS, including 101 up-regulated ones and 146 down-regulated ones. With validation by RT-qPCR detection, miR-409-3p was selected for subsequent assays. Administrations of rTMS improved cognitive behaviors of mice, increased neuron number, and attenuated brain injuries induced by 6-OHDA. The cerebrospinal fluid (CSF) level of Aβ1-42 was induced, while the brain level of Aβ1-42 was suppressed by rTMS. Regarding miR-409-3p/PDHB axis, rTMS administrations suppressed miR-409-3p level and increased the expression of PDHB.
Conclusion: Administrations of rTMS showed considerable protective effects on brain tissues against PD-induced injuries, which was associated with the changes in miR levels. The current study demonstrated that the inhibition of miR-409-3p by rTMS contributed to the attenuation of PD by inducing PDHB.
Similar articles
-
Repetitive transcranial magnetic stimulation protects mice against 6-OHDA-induced Parkinson's disease symptoms by regulating brain amyloid β1-42 level.Mol Cell Biochem. 2019 Aug;458(1-2):71-78. doi: 10.1007/s11010-019-03531-w. Epub 2019 Apr 19. Mol Cell Biochem. 2019. PMID: 31004306
-
Administration of rTMS Alleviates Stroke-Induced Cognitive Deficits by Modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis.J Mol Neurosci. 2022 Mar;72(3):507-515. doi: 10.1007/s12031-021-01924-5. Epub 2021 Oct 16. J Mol Neurosci. 2022. PMID: 34655390
-
Repetitive Transcranial Magnetic Stimulation Improves Mild Cognitive Impairment Associated with Alzheimer's Disease in Mice by Modulating the miR-567/NEUROD2/PSD95 Axis.Neuropsychiatr Dis Treat. 2021 Jul 2;17:2151-2161. doi: 10.2147/NDT.S311183. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34239303 Free PMC article.
-
Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation.Neurophysiol Clin. 2006 May-Jun;36(3):125-33. doi: 10.1016/j.neucli.2006.08.003. Epub 2006 Aug 22. Neurophysiol Clin. 2006. PMID: 17046607 Review.
-
Repetitive transcranial magnetic stimulation therapy for motor recovery in Parkinson's disease: A Meta-analysis.Brain Behav. 2018 Nov;8(11):e01132. doi: 10.1002/brb3.1132. Epub 2018 Sep 28. Brain Behav. 2018. PMID: 30264518 Free PMC article.
Cited by
-
Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes.Mol Neurobiol. 2025 Aug;62(8):10118-10132. doi: 10.1007/s12035-025-04890-w. Epub 2025 Apr 4. Mol Neurobiol. 2025. PMID: 40184025 Free PMC article.
-
A cuproptosis-based prognostic model for predicting survival in low-grade glioma.Aging (Albany NY). 2024 May 9;16(10):8697-8716. doi: 10.18632/aging.205834. Epub 2024 May 9. Aging (Albany NY). 2024. PMID: 38738989 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical